Testing Adaptive Therapy Protocols Using Gemcitabine and Capecitabine in a Preclinical Model of Endocrine-Resistant Breast Cancer

Adaptive therapy, an ecologically inspired approach to cancer treatment, aims to overcome resistance and reduce toxicity by leveraging competitive interactions between drug-sensitive and drug-resistant subclones, prioritizing patient survival and quality of life instead of killing the maximum number...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2024-01, Vol.16 (2), p.257
Hauptverfasser:	Seyedi, Sareh, Teo, Ruthanne, Foster, Luke, Saha, Daniel, Mina, Lida, Northfelt, Donald, Anderson, Karen S, Shibata, Darryl, Gatenby, Robert, Cisneros, Luis H, Troan, Brigid, Anderson, Alexander R A, Maley, Carlo C
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimitotic agents Antineoplastic agents Apoptosis Breast cancer Cancer therapies Cell cycle Cell proliferation Clinical trials Drug dosages Drug resistance Estrogens Gemcitabine Health aspects Metastasis Pesticides Prostate cancer Quality of life Standard of care Toxicity Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!